Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017393

CEO and Chairman sold 4,424 shares at $12.01 ($53,132)

  • CEO and Chairman acquired 247,117 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2022-03-04 Grant or award +247,117 1,920,578 D: show line 1 in the form
ROBINS CHAD M CEO and Chairman 2022-03-07 Sale −4,424 $12.01 $53,132 1,916,154 D: show line 2 in the form
Open-market sales · 4,424 sh · avg $12.01 · $53,132
Loading xslF345X03/doc4.xml…